387261006: Nalidixic acid (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Antibacterial\Quinolone antibacterial\Nalidixic acid (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Anti-infective agent (substance)\Antibacterial\Quinolone antibacterial\Nalidixic acid (substance)
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Quinoline\Quinolone (substance)\Quinolone antibacterial\Nalidixic acid (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amine and/or amine derivative\Quinoline\Quinolone (substance)\Quinolone antibacterial\Nalidixic acid (substance)

\Organic compound\Organic cyclic compound\Heterocyclic compound\Quinoline\Quinolone (substance)\Quinolone antibacterial\Nalidixic acid (substance)
\Organic compound\Organic nitrogen compound\Amine and/or amine derivative\Quinoline\Quinolone (substance)\Quinolone antibacterial\Nalidixic acid (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Nalidixic acid (substance)	Is a	Quinolone antibacterial	true	Inferred relationship	Some
Nalidixic acid (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Antibacterial (disposition)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Nalidixate measurement	Component	True	Nalidixic acid (substance)	Inferred relationship	Some	1
Nalidixic acid adverse reaction	Causative agent (attribute)	False	Nalidixic acid (substance)	Inferred relationship	Some
Allergy to nalidixic acid	Causative agent (attribute)	False	Nalidixic acid (substance)	Inferred relationship	Some
Nalidixic acid 500 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Nalidixic acid (substance)	Inferred relationship	Some
Nalidixic acid 60 mg/mL oral suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Nalidixic acid (substance)	Inferred relationship	Some
Nalidixic acid+sodium citrate 660mg/sachet effervescent granules	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Nalidixic acid (substance)	Inferred relationship	Some
Nalidixic acid 300mg/5mL s/f suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Nalidixic acid (substance)	Inferred relationship	Some
Nalidixic acid 250 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Nalidixic acid (substance)	Inferred relationship	Some
Product containing precisely nalidixic acid 50 milligram/1 milliliter conventional release oral suspension (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Nalidixic acid (substance)	Inferred relationship	Some
Nalidixic acid 1 g oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Nalidixic acid (substance)	Inferred relationship	Some
Product containing nalidixic acid (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Nalidixic acid (substance)	Inferred relationship	Some	1
Product containing disodium citrate and nalidixic acid	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Nalidixic acid (substance)	Inferred relationship	Some
Nalidixic acid adverse reaction (disorder)	Causative agent (attribute)	True	Nalidixic acid (substance)	Inferred relationship	Some	1
Nalidixic acid sensitivity	Causative agent (attribute)	False	Nalidixic acid (substance)	Inferred relationship	Some	1
Allergy to nalidixic acid	Causative agent (attribute)	True	Nalidixic acid (substance)	Inferred relationship	Some	1
Nalidixic acid 500 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Nalidixic acid (substance)	Inferred relationship	Some	1
Nalidixic acid 500 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Nalidixic acid (substance)	Inferred relationship	Some	1
Nalidixic acid 250 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Nalidixic acid (substance)	Inferred relationship	Some	1
Nalidixic acid 250 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Nalidixic acid (substance)	Inferred relationship	Some	1
Nalidixic acid 1 g oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Nalidixic acid (substance)	Inferred relationship	Some	1
Nalidixic acid 1 g oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Nalidixic acid (substance)	Inferred relationship	Some	1
Nalidixic acid 1 g oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Nalidixic acid (substance)	Inferred relationship	Some	1
Nalidixic acid 500 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Nalidixic acid (substance)	Inferred relationship	Some	1
Nalidixic acid 250 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Nalidixic acid (substance)	Inferred relationship	Some	1
Nalidixic acid-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Nalidixic acid (substance)	Inferred relationship	Some	1
Nalidixic acid 60 mg/mL oral suspension	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Nalidixic acid (substance)	Inferred relationship	Some	1
Nalidixic acid 60 mg/mL oral suspension	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Nalidixic acid (substance)	Inferred relationship	Some	1
Product containing citric acid and nalidixic acid (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Nalidixic acid (substance)	Inferred relationship	Some	1
Product containing only citric acid and nalidixic acid (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Nalidixic acid (substance)	Inferred relationship	Some	1
Product containing only nalidixic acid (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Nalidixic acid (substance)	Inferred relationship	Some	1
Nalidixic acid only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Nalidixic acid (substance)	Inferred relationship	Some	1
Product containing precisely nalidixic acid 50 milligram/1 milliliter conventional release oral suspension (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Nalidixic acid (substance)	Inferred relationship	Some	1
Product containing precisely nalidixic acid 50 milligram/1 milliliter conventional release oral suspension (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Nalidixic acid (substance)	Inferred relationship	Some	1
Hypersensitivity to nalidixic acid (finding)	Causative agent (attribute)	True	Nalidixic acid (substance)	Inferred relationship	Some	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1461439011	Nalidixic acid (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1481363010	Nalidixic acid	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1491964013	Nalidixinic acid	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
367571000195119	acido nalidixico	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
826931000172111	acide nalidixique	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module